These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 32027419)
1. Effects of constant light exposure on sphingolipidomics and progression of NASH in high-fat-fed rats. Yue F; Xia K; Wei L; Xing L; Wu S; Shi Y; Lam SM; Shui G; Xiang X; Russell R; Zhang D J Gastroenterol Hepatol; 2020 Nov; 35(11):1978-1989. PubMed ID: 32027419 [TBL] [Abstract][Full Text] [Related]
2. Constant Light Exposure Alters Gut Microbiota and Promotes the Progression of Steatohepatitis in High Fat Diet Rats. Wei L; Yue F; Xing L; Wu S; Shi Y; Li J; Xiang X; Lam SM; Shui G; Russell R; Zhang D Front Microbiol; 2020; 11():1975. PubMed ID: 32973715 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis. Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005 [TBL] [Abstract][Full Text] [Related]
4. Chronic constant light exposure aggravates high fat diet-induced renal injury in rats. Xing L; Wu S; Shi Y; Yue F; Wei L; Russell R; Zhang D Front Endocrinol (Lausanne); 2022; 13():900392. PubMed ID: 35966094 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929 [TBL] [Abstract][Full Text] [Related]
6. Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover. Simon J; Ouro A; Ala-Ibanibo L; Presa N; Delgado TC; Martínez-Chantar ML Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861664 [TBL] [Abstract][Full Text] [Related]
7. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats. Liu J; Han L; Zhu L; Yu Y Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515 [TBL] [Abstract][Full Text] [Related]
8. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats. Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377 [TBL] [Abstract][Full Text] [Related]
9. Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer. Wang K; Wei Y; Xu R; Li Y; Mao C Adv Exp Med Biol; 2022; 1372():157-168. PubMed ID: 35503180 [TBL] [Abstract][Full Text] [Related]
10. The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome. Lu Z; Li Y; Chowdhury N; Yu H; Syn WK; Lopes-Virella M; Yilmaz Ö; Huang Y Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176029 [TBL] [Abstract][Full Text] [Related]
11. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet. Kasbi-Chadli F; Ferchaud-Roucher V; Krempf M; Ouguerram K Eur J Nutr; 2016 Mar; 55(2):589-599. PubMed ID: 25787885 [TBL] [Abstract][Full Text] [Related]
12. FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. Rohrbach TD; Asgharpour A; Maczis MA; Montefusco D; Cowart LA; Bedossa P; Sanyal AJ; Spiegel S J Lipid Res; 2019 Jul; 60(7):1311-1322. PubMed ID: 31110049 [TBL] [Abstract][Full Text] [Related]
13. Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease. Zhu C; Huai Q; Zhang X; Dai H; Li X; Wang H Int J Biol Sci; 2023; 19(1):311-330. PubMed ID: 36594091 [TBL] [Abstract][Full Text] [Related]
14. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145 [TBL] [Abstract][Full Text] [Related]
15. Lipidomic Analysis of Liver and Adipose Tissue in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice Model Reveals Alterations in Lipid Metabolism by Weight Loss and Aerobic Exercise. Mouskeftara T; Deda O; Papadopoulos G; Chatzigeorgiou A; Gika H Molecules; 2024 Mar; 29(7):. PubMed ID: 38611773 [TBL] [Abstract][Full Text] [Related]
16. Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD. Sztolsztener K; Konstantynowicz-Nowicka K; Harasim-Symbor E; Chabowski A Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830360 [TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease: Insights from sphingolipidomics. Montefusco DJ; Allegood JC; Spiegel S; Cowart LA Biochem Biophys Res Commun; 2018 Oct; 504(3):608-616. PubMed ID: 29778532 [TBL] [Abstract][Full Text] [Related]
18. Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats. Gerges SH; Wahdan SA; Elsherbiny DA; El-Demerdash E Toxicol Appl Pharmacol; 2020 Aug; 401():115101. PubMed ID: 32512072 [TBL] [Abstract][Full Text] [Related]
19. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis. Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026 [TBL] [Abstract][Full Text] [Related]
20. Constant light exposure alters gut microbiota and short-/medium-chain fatty acids and aggravates PCOS-like traits in HFD-fed rats. Yue F; Xing L; Wu S; Wei L; Zhou Z; Shi Y; Lam SM; Shui G; Xiang X; Russell R; Zhang D Obesity (Silver Spring); 2022 Mar; 30(3):694-706. PubMed ID: 35128797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]